| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
111,337 |
101,434 |
$17.69M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
35,176 |
31,434 |
$12.57M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
63,640 |
59,284 |
$9.59M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
45,698 |
41,674 |
$8.46M |
| G0378 |
Hospital observation service, per hour |
27,317 |
20,594 |
$4.97M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
43,249 |
38,024 |
$2.92M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
4,633 |
4,534 |
$2.59M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
17,985 |
14,387 |
$2.44M |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
3,464 |
3,416 |
$2.43M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
16,951 |
16,115 |
$2.31M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
15,211 |
13,738 |
$2.08M |
| 70450 |
Computed tomography, head or brain; without contrast material |
16,652 |
15,364 |
$1.99M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
2,647 |
2,609 |
$1.72M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
13,528 |
12,335 |
$1.66M |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
13,133 |
12,821 |
$1.56M |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
11,950 |
11,183 |
$1.54M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
44,659 |
36,795 |
$1.52M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
54,912 |
53,353 |
$1.32M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
54,755 |
53,190 |
$1.31M |
| S9485 |
Crisis intervention mental health services, per diem |
2,514 |
2,161 |
$1.26M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
8,028 |
4,008 |
$1.16M |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
18,648 |
18,498 |
$1.15M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,550 |
9,685 |
$1.13M |
| 76830 |
Ultrasound, transvaginal |
11,872 |
11,604 |
$1.10M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
7,952 |
7,465 |
$1.09M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
1,171 |
1,114 |
$1.05M |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
7,249 |
7,125 |
$1.01M |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
7,354 |
5,854 |
$946K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
3,353 |
3,219 |
$941K |
| 90834 |
Psychotherapy, 45 minutes with patient |
33,844 |
17,074 |
$930K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
26,276 |
23,160 |
$908K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
203,981 |
167,781 |
$861K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
5,181 |
5,050 |
$811K |
| 71046 |
Radiologic examination, chest; 2 views |
42,086 |
39,599 |
$799K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
3,861 |
3,344 |
$792K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
5,210 |
5,007 |
$787K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
5,095 |
4,687 |
$768K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
3,600 |
3,402 |
$747K |
| 84443 |
Thyroid stimulating hormone (TSH) |
84,450 |
82,231 |
$731K |
| 76801 |
|
5,281 |
4,794 |
$679K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
41,158 |
40,583 |
$659K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
3,760 |
3,618 |
$656K |
| 86480 |
|
15,642 |
15,436 |
$644K |
| 93971 |
|
4,197 |
4,014 |
$643K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
22,341 |
22,139 |
$587K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
11,068 |
7,156 |
$585K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
3,495 |
3,358 |
$581K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
6,201 |
5,925 |
$575K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
37,007 |
36,387 |
$571K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
29,092 |
25,001 |
$557K |
| 59025 |
Fetal non-stress test |
2,155 |
1,855 |
$541K |
| 76642 |
|
5,731 |
5,085 |
$494K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,866 |
2,847 |
$471K |
| 76770 |
|
3,239 |
3,161 |
$470K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
5,551 |
3,140 |
$450K |
| 76536 |
|
4,626 |
4,528 |
$447K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
2,317 |
2,210 |
$429K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
2,076 |
1,951 |
$426K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
83,460 |
77,489 |
$426K |
| 85027 |
|
112,111 |
105,442 |
$416K |
| 93975 |
|
6,010 |
5,843 |
$408K |
| 74183 |
|
1,933 |
1,870 |
$407K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
17,400 |
15,983 |
$404K |
| ATP08 |
|
69,421 |
55,525 |
$401K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
78,815 |
77,561 |
$398K |
| J3490 |
Unclassified drugs |
21,041 |
16,733 |
$373K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,344 |
6,124 |
$372K |
| 70496 |
|
2,217 |
2,105 |
$366K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
455 |
449 |
$356K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
18,530 |
18,413 |
$354K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
16,705 |
14,764 |
$335K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
5,637 |
4,811 |
$327K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
41,175 |
36,790 |
$321K |
| ATP15 |
|
37,634 |
30,997 |
$310K |
| 99215 |
Prolong outpt/office vis |
2,736 |
2,436 |
$308K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
14,751 |
14,608 |
$305K |
| 87631 |
|
3,853 |
3,727 |
$300K |
| 84484 |
|
34,273 |
28,860 |
$293K |
| 71250 |
|
5,178 |
4,993 |
$291K |
| 86803 |
|
33,961 |
33,460 |
$290K |
| 12001 |
|
1,361 |
1,309 |
$287K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
26,192 |
17,506 |
$282K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
12,048 |
11,797 |
$281K |
| 94060 |
|
3,043 |
2,922 |
$279K |
| 97803 |
|
3,853 |
3,291 |
$279K |
| 86780 |
|
29,934 |
29,461 |
$278K |
| 93017 |
|
3,085 |
2,999 |
$275K |
| 77080 |
|
5,927 |
5,856 |
$273K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
390 |
385 |
$271K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
12,731 |
11,411 |
$251K |
| 83655 |
|
22,979 |
22,868 |
$237K |
| 87070 |
|
37,749 |
36,275 |
$235K |
| 72141 |
|
1,465 |
1,387 |
$232K |
| 90791 |
Psychiatric diagnostic evaluation |
7,037 |
6,016 |
$230K |
| ATP17 |
|
33,532 |
30,881 |
$229K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
633 |
604 |
$224K |
| 77062 |
|
3,029 |
2,987 |
$221K |
| 64493 |
|
306 |
256 |
$218K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
3,172 |
2,996 |
$210K |
| 82728 |
|
25,709 |
25,100 |
$206K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
200,217 |
161,222 |
$206K |
| ATP14 |
|
32,398 |
29,526 |
$203K |
| 73564 |
|
8,668 |
7,614 |
$203K |
| 83880 |
|
13,582 |
12,186 |
$202K |
| 73221 |
|
1,159 |
1,083 |
$198K |
| 84702 |
|
16,014 |
12,907 |
$196K |
| 83735 |
|
55,999 |
43,472 |
$194K |
| 82607 |
|
25,361 |
24,900 |
$183K |
| 71045 |
Radiologic examination, chest; single view |
23,241 |
21,200 |
$182K |
| 83970 |
|
10,567 |
10,284 |
$182K |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
521 |
80 |
$171K |
| 97802 |
|
2,558 |
2,450 |
$168K |
| 80050 |
General health panel |
11,903 |
11,720 |
$167K |
| 83690 |
|
37,038 |
33,745 |
$165K |
| 72100 |
|
4,619 |
4,509 |
$162K |
| 47562 |
|
58 |
54 |
$160K |
| 77061 |
|
1,835 |
1,817 |
$156K |
| 87186 |
|
29,349 |
27,739 |
$149K |
| 73630 |
|
6,566 |
6,057 |
$148K |
| 87077 |
|
31,994 |
30,283 |
$148K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13,412 |
11,938 |
$148K |
| 12011 |
|
695 |
675 |
$148K |
| 93970 |
|
756 |
720 |
$146K |
| 95811 |
|
171 |
160 |
$139K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
4,525 |
4,298 |
$139K |
| 81025 |
|
25,368 |
23,640 |
$138K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,560 |
2,352 |
$137K |
| 73130 |
|
5,751 |
5,036 |
$135K |
| 73610 |
|
5,868 |
5,527 |
$132K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
582 |
555 |
$132K |
| 84439 |
|
26,241 |
25,447 |
$128K |
| 73030 |
|
5,354 |
4,971 |
$126K |
| 77065 |
Tomosynthesis, mammo |
3,362 |
3,123 |
$125K |
| 94726 |
|
2,727 |
2,630 |
$122K |
| 76882 |
|
1,312 |
1,206 |
$121K |
| 87340 |
|
17,896 |
17,632 |
$121K |
| 80053 |
Comprehensive metabolic panel |
104,957 |
98,891 |
$119K |
| 87536 |
|
2,421 |
2,366 |
$117K |
| 86850 |
|
16,182 |
15,122 |
$114K |
| 87522 |
Neg quan hep c or qual rna |
4,142 |
4,016 |
$113K |
| 76870 |
|
1,247 |
1,209 |
$113K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
1,030 |
995 |
$111K |
| 93976 |
|
1,274 |
1,244 |
$109K |
| 83550 |
|
21,682 |
21,258 |
$109K |
| 86706 |
|
15,982 |
15,724 |
$108K |
| 94729 |
|
2,726 |
2,629 |
$106K |
| 84153 |
|
11,919 |
11,665 |
$106K |
| 10060 |
|
657 |
613 |
$101K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
947 |
908 |
$99K |
| 19083 |
|
134 |
126 |
$97K |
| 93296 |
|
3,893 |
3,799 |
$97K |
| 86003 |
|
2,829 |
2,780 |
$96K |
| ATP03 |
|
19,777 |
18,232 |
$95K |
| 80061 |
Lipid panel |
109,766 |
107,890 |
$94K |
| 74019 |
|
2,760 |
2,660 |
$92K |
| 81001 |
|
56,387 |
51,931 |
$89K |
| 97161 |
|
2,510 |
2,303 |
$88K |
| 83540 |
|
23,894 |
23,389 |
$87K |
| 88112 |
|
2,880 |
2,777 |
$87K |
| 43235 |
|
141 |
138 |
$85K |
| 86704 |
|
10,928 |
10,797 |
$83K |
| 12002 |
|
416 |
396 |
$83K |
| 73110 |
|
3,409 |
3,119 |
$82K |
| 87040 |
|
7,606 |
6,900 |
$82K |
| 84402 |
|
4,985 |
4,903 |
$80K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
63,956 |
55,103 |
$80K |
| 81513 |
|
765 |
748 |
$79K |
| 86140 |
|
25,271 |
23,130 |
$78K |
| 72197 |
|
306 |
304 |
$78K |
| 86787 |
|
7,932 |
7,818 |
$78K |
| 86762 |
|
6,970 |
6,869 |
$78K |
| 84146 |
|
6,063 |
5,796 |
$76K |
| 85610 |
|
52,554 |
32,153 |
$75K |
| 74246 |
|
419 |
411 |
$74K |
| 74018 |
|
2,839 |
2,712 |
$73K |
| 84403 |
|
4,819 |
4,701 |
$72K |
| 82784 |
|
10,161 |
9,922 |
$72K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
5,792 |
3,209 |
$72K |
| 78451 |
|
195 |
192 |
$70K |
| 83605 |
|
9,810 |
8,723 |
$69K |
| 86618 |
|
6,351 |
6,227 |
$68K |
| 77066 |
Tomosynthesis, mammo |
3,755 |
3,673 |
$66K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,554 |
5,379 |
$66K |
| 90715 |
|
2,907 |
2,787 |
$66K |
| ATP11 |
|
11,702 |
10,757 |
$66K |
| 80076 |
|
81,141 |
72,323 |
$66K |
| 86235 |
|
1,831 |
1,790 |
$63K |
| 73502 |
|
2,753 |
2,646 |
$61K |
| 82043 |
|
25,855 |
25,250 |
$61K |
| 87081 |
|
12,858 |
12,365 |
$61K |
| 82670 |
|
3,394 |
3,266 |
$61K |
| 70486 |
|
1,342 |
1,273 |
$60K |
| 82274 |
|
7,858 |
7,755 |
$59K |
| 84703 |
|
10,333 |
9,727 |
$57K |
| J0574 |
Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine |
1,349 |
578 |
$56K |
| 87338 |
|
6,132 |
6,066 |
$56K |
| 82803 |
|
3,592 |
3,299 |
$55K |
| 83001 |
|
4,494 |
4,391 |
$54K |
| 64483 |
|
104 |
89 |
$52K |
| 86360 |
|
2,176 |
2,132 |
$51K |
| 71271 |
|
1,560 |
1,519 |
$51K |
| 86665 |
|
1,888 |
1,844 |
$50K |
| 82746 |
|
6,790 |
6,679 |
$48K |
| 93225 |
|
694 |
676 |
$46K |
| ATP16 |
|
6,117 |
4,619 |
$45K |
| ATP18 |
|
7,656 |
6,922 |
$45K |
| 73140 |
|
1,800 |
1,726 |
$44K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
7,071 |
6,488 |
$44K |
| 93270 |
|
821 |
811 |
$44K |
| 83516 |
|
4,535 |
4,430 |
$43K |
| 86900 |
|
15,790 |
14,786 |
$43K |
| 72050 |
|
798 |
779 |
$42K |
| ATP07 |
|
7,099 |
6,660 |
$42K |
| 83020 |
|
3,977 |
3,941 |
$42K |
| ATP09 |
|
7,753 |
5,904 |
$41K |
| 86359 |
|
2,178 |
2,134 |
$41K |
| 86038 |
|
5,974 |
5,874 |
$40K |
| 87106 |
|
4,823 |
4,702 |
$39K |
| 85379 |
|
6,102 |
5,829 |
$39K |
| 83002 |
|
3,208 |
3,132 |
$39K |
| 87517 |
|
1,518 |
1,471 |
$38K |
| 88360 |
|
611 |
580 |
$38K |
| 85652 |
|
24,679 |
22,851 |
$38K |
| J7050 |
Infusion, normal saline solution, 250 cc |
19,241 |
12,275 |
$38K |
| 93308 |
|
185 |
173 |
$37K |
| 81003 |
|
30,430 |
28,749 |
$37K |
| 70491 |
|
229 |
216 |
$36K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
1,334 |
1,162 |
$36K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
26,497 |
21,580 |
$35K |
| 86901 |
|
15,791 |
14,781 |
$35K |
| 88342 |
|
5,868 |
5,698 |
$34K |
| 87205 |
|
12,669 |
12,112 |
$34K |
| 84480 |
|
4,722 |
4,481 |
$34K |
| 84425 |
|
2,474 |
2,455 |
$34K |
| 10005 |
|
89 |
88 |
$34K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
1,236 |
1,121 |
$33K |
| 87529 |
|
1,489 |
1,452 |
$33K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
27,711 |
23,880 |
$33K |
| 88173 |
|
531 |
495 |
$32K |
| 88307 |
|
367 |
316 |
$32K |
| ATP10 |
|
7,016 |
6,080 |
$30K |
| 73080 |
|
1,688 |
1,580 |
$30K |
| 96118 |
|
28 |
28 |
$29K |
| 95816 |
|
125 |
114 |
$29K |
| G0105 |
Colorectal cancer screening; colonoscopy on individual at high risk |
56 |
56 |
$29K |
| 87046 |
|
4,314 |
4,171 |
$28K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
33 |
26 |
$28K |
| 96367 |
|
1,024 |
930 |
$27K |
| 72070 |
|
836 |
817 |
$26K |
| 70498 |
|
2,021 |
1,907 |
$26K |
| 86160 |
|
2,114 |
2,066 |
$25K |
| J7999 |
Compounded drug, not otherwise classified |
2,372 |
1,791 |
$25K |
| 49083 |
|
43 |
26 |
$25K |
| J9999 |
Not otherwise classified, antineoplastic drugs |
1,740 |
959 |
$24K |
| 87045 |
|
4,228 |
4,093 |
$24K |
| 70544 |
|
138 |
130 |
$23K |
| 83993 |
|
1,905 |
1,874 |
$23K |
| 87481 |
|
767 |
751 |
$23K |
| 72170 |
|
2,292 |
2,138 |
$22K |
| J1644 |
Injection, heparin sodium, per 1000 units |
7,508 |
3,917 |
$22K |
| 87430 |
|
2,172 |
2,086 |
$22K |
| 80164 |
|
4,646 |
4,267 |
$22K |
| 86664 |
|
1,880 |
1,844 |
$22K |
| 86696 |
|
1,357 |
1,336 |
$22K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
25,716 |
22,666 |
$22K |
| 83013 |
|
562 |
561 |
$22K |
| 88304 |
|
1,831 |
1,726 |
$21K |
| 86200 |
|
2,822 |
2,776 |
$21K |
| 93226 |
|
652 |
636 |
$21K |
| 82627 |
|
1,349 |
1,330 |
$21K |
| 86695 |
|
1,940 |
1,913 |
$20K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
7,817 |
5,481 |
$20K |
| 86334 |
|
2,111 |
2,069 |
$20K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
1,104 |
645 |
$20K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
159 |
159 |
$20K |
| 83498 |
|
957 |
943 |
$20K |
| 83520 |
|
2,193 |
2,147 |
$19K |
| 82947 |
|
8,212 |
8,095 |
$19K |
| 99443 |
|
1,781 |
1,745 |
$19K |
| 85730 |
|
5,217 |
4,806 |
$19K |
| ATP02 |
|
4,530 |
3,610 |
$19K |
| 82951 |
|
1,613 |
1,604 |
$19K |
| 82533 |
|
2,076 |
1,785 |
$19K |
| 73590 |
|
1,204 |
1,096 |
$19K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
240 |
240 |
$19K |
| 82785 |
|
1,846 |
1,817 |
$19K |
| 86735 |
|
2,265 |
2,213 |
$18K |
| 86677 |
|
1,730 |
1,694 |
$18K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
787 |
770 |
$18K |
| 36415 |
Collection of venous blood by venipuncture |
108,636 |
82,183 |
$18K |
| 82024 |
|
987 |
960 |
$18K |
| 82105 |
|
1,852 |
1,793 |
$18K |
| 84165 |
|
4,118 |
4,041 |
$18K |
| 87902 |
|
240 |
228 |
$18K |
| 86376 |
|
2,100 |
2,064 |
$18K |
| 80197 |
|
4,957 |
3,114 |
$17K |
| 58558 |
|
13 |
13 |
$17K |
| 86039 |
|
2,367 |
2,304 |
$16K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
16,945 |
14,425 |
$16K |
| 87300 |
|
1,911 |
1,862 |
$16K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,427 |
4,128 |
$15K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
10,382 |
8,224 |
$15K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
906 |
884 |
$15K |
| 86765 |
|
1,912 |
1,865 |
$14K |
| 86708 |
|
1,966 |
1,943 |
$14K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
13,828 |
12,516 |
$14K |
| 82570 |
|
5,603 |
5,051 |
$14K |
| 83721 |
|
3,960 |
3,889 |
$14K |
| 95819 |
|
68 |
53 |
$13K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
622 |
560 |
$13K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
5,125 |
3,894 |
$13K |
| 99201 |
|
115 |
108 |
$13K |
| 86225 |
|
1,586 |
1,564 |
$13K |
| 83883 |
|
1,159 |
1,129 |
$13K |
| J2704 |
Injection, propofol, 10 mg |
19,097 |
16,907 |
$12K |
| 36430 |
|
49 |
26 |
$12K |
| 86431 |
|
3,637 |
3,568 |
$12K |
| 87641 |
|
455 |
443 |
$12K |
| 84445 |
|
361 |
359 |
$12K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
82 |
79 |
$12K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
1,016 |
755 |
$12K |
| 74221 |
|
98 |
97 |
$12K |
| 80177 |
|
1,699 |
1,537 |
$11K |
| 80178 |
|
3,622 |
3,237 |
$11K |
| ATP04 |
|
2,055 |
1,848 |
$11K |
| 86255 |
|
1,389 |
1,317 |
$11K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
5,144 |
4,217 |
$11K |
| 76942 |
|
65 |
65 |
$10K |
| 84100 |
|
20,710 |
15,779 |
$10K |
| 83525 |
|
1,543 |
1,517 |
$10K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
314 |
297 |
$10K |
| 85045 |
|
4,473 |
3,891 |
$10K |
| J2060 |
Injection, lorazepam, 2 mg |
8,110 |
6,624 |
$10K |
| 82150 |
|
2,132 |
2,019 |
$10K |
| 84270 |
|
618 |
610 |
$10K |
| 86141 |
|
1,795 |
1,682 |
$10K |
| 73700 |
|
66 |
64 |
$9K |
| 84144 |
|
726 |
672 |
$9K |
| 81002 |
|
4,281 |
4,119 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,187 |
3,858 |
$9K |
| 85397 |
|
459 |
454 |
$9K |
| 31500 |
|
20 |
20 |
$9K |
| 72158 |
|
82 |
80 |
$9K |
| 87177 |
|
1,514 |
1,469 |
$9K |
| ATP05 |
|
1,382 |
1,281 |
$9K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
7,245 |
6,675 |
$9K |
| 87449 |
|
1,330 |
1,228 |
$9K |
| 93280 |
|
379 |
373 |
$9K |
| 88172 |
|
408 |
381 |
$9K |
| 84156 |
|
4,261 |
3,696 |
$8K |
| ATP13 |
|
1,566 |
1,424 |
$8K |
| 86769 |
|
274 |
269 |
$8K |
| 82330 |
|
1,653 |
1,561 |
$8K |
| 74178 |
|
61 |
61 |
$8K |
| ATP06 |
|
1,117 |
1,056 |
$8K |
| 82565 |
|
9,311 |
8,366 |
$8K |
| 85246 |
|
459 |
454 |
$8K |
| 82610 |
|
1,265 |
1,175 |
$7K |
| 94002 |
|
14 |
12 |
$7K |
| 72082 |
|
100 |
98 |
$7K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
6,792 |
5,521 |
$7K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
159 |
90 |
$7K |
| 84432 |
|
693 |
670 |
$6K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,977 |
1,227 |
$6K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,644 |
4,068 |
$6K |
| 80074 |
|
174 |
168 |
$6K |
| ATP23 |
|
648 |
500 |
$6K |
| 82088 |
|
312 |
294 |
$6K |
| 85240 |
|
474 |
466 |
$6K |
| 82948 |
|
2,441 |
1,683 |
$6K |
| 71101 |
|
126 |
124 |
$6K |
| 84436 |
|
1,430 |
1,406 |
$6K |
| 80159 |
|
1,114 |
866 |
$6K |
| 62323 |
|
12 |
12 |
$6K |
| 90686 |
|
472 |
460 |
$6K |
| 82140 |
|
846 |
744 |
$6K |
| 82550 |
|
7,179 |
6,461 |
$6K |
| 86147 |
|
158 |
156 |
$6K |
| 86364 |
|
4,266 |
4,211 |
$5K |
| 86341 |
|
520 |
512 |
$5K |
| 82952 |
|
1,610 |
1,601 |
$5K |
| 86800 |
|
766 |
746 |
$5K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
48 |
35 |
$5K |
| 87076 |
|
1,939 |
1,823 |
$5K |
| J1756 |
Injection, iron sucrose, 1 mg |
372 |
165 |
$5K |
| ATP12 |
|
1,225 |
1,100 |
$5K |
| 86308 |
|
1,278 |
1,249 |
$5K |
| 87324 |
|
799 |
744 |
$5K |
| 82985 |
|
831 |
820 |
$5K |
| 84460 |
|
9,010 |
8,719 |
$5K |
| 84681 |
|
509 |
495 |
$5K |
| 93880 |
|
56 |
53 |
$5K |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
1,148 |
594 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
48 |
47 |
$5K |
| 87799 |
|
412 |
307 |
$5K |
| 74181 |
|
26 |
26 |
$5K |
| 73090 |
|
442 |
430 |
$5K |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
14,540 |
7,930 |
$5K |
| 84550 |
|
6,769 |
6,408 |
$4K |
| 84166 |
|
414 |
407 |
$4K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
167 |
63 |
$4K |
| 86592 |
|
1,452 |
1,429 |
$4K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,155 |
919 |
$4K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
3,847 |
2,857 |
$4K |
| 80069 |
|
6,993 |
6,168 |
$4K |
| 80175 |
|
629 |
589 |
$4K |
| 84207 |
|
269 |
268 |
$4K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,175 |
424 |
$4K |
| 87625 |
|
158 |
158 |
$4K |
| 10022 |
|
26 |
24 |
$4K |
| 74174 |
|
100 |
99 |
$4K |
| 80299 |
|
351 |
326 |
$4K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
326 |
294 |
$4K |
| 83521 |
|
1,305 |
1,279 |
$4K |
| 84450 |
|
7,521 |
7,208 |
$4K |
| 84305 |
|
269 |
262 |
$4K |
| 84630 |
|
415 |
415 |
$4K |
| 90656 |
|
211 |
206 |
$4K |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
250 |
127 |
$4K |
| 76981 |
|
46 |
46 |
$4K |
| 88346 |
|
52 |
50 |
$4K |
| 86705 |
|
449 |
441 |
$4K |
| 93297 |
|
316 |
305 |
$3K |
| 84132 |
|
4,265 |
3,945 |
$3K |
| 74220 |
|
58 |
54 |
$3K |
| 20610 |
|
24 |
24 |
$3K |
| 84154 |
|
447 |
436 |
$3K |
| 82248 |
|
7,005 |
5,622 |
$3K |
| 82010 |
|
534 |
487 |
$3K |
| 82390 |
|
433 |
421 |
$3K |
| 99442 |
|
818 |
805 |
$3K |
| 82977 |
|
2,571 |
2,476 |
$3K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
16,168 |
13,793 |
$3K |
| C7901 |
Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service |
584 |
298 |
$3K |
| 82465 |
|
1,387 |
1,369 |
$3K |
| 85018 |
|
2,243 |
1,894 |
$3K |
| 84244 |
|
228 |
223 |
$3K |
| 82103 |
|
317 |
312 |
$3K |
| 86617 |
|
268 |
256 |
$2K |
| 82962 |
|
17,055 |
12,806 |
$2K |
| 85014 |
|
2,108 |
1,770 |
$2K |
| J1630 |
Injection, haloperidol, up to 5 mg |
2,693 |
2,339 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,363 |
2,148 |
$2K |
| 82626 |
|
117 |
115 |
$2K |
| 83010 |
|
325 |
307 |
$2K |
| 85048 |
|
2,191 |
1,800 |
$2K |
| 82310 |
|
2,291 |
2,171 |
$2K |
| 99385 |
|
13 |
13 |
$2K |
| 0002A |
|
55 |
51 |
$2K |
| 72156 |
|
25 |
25 |
$2K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
342 |
201 |
$2K |
| 97165 |
|
31 |
27 |
$2K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
3,141 |
3,060 |
$2K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
835 |
698 |
$2K |
| 89051 |
|
479 |
417 |
$2K |
| 84590 |
|
249 |
247 |
$2K |
| 81050 |
|
1,035 |
1,006 |
$2K |
| 93298 |
|
152 |
141 |
$2K |
| 84300 |
|
597 |
473 |
$2K |
| 93797 |
|
37 |
14 |
$2K |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
630 |
592 |
$2K |
| 88312 |
|
131 |
129 |
$2K |
| 87640 |
|
219 |
212 |
$2K |
| 80156 |
|
371 |
351 |
$2K |
| 96376 |
|
5,583 |
4,654 |
$2K |
| 87103 |
|
162 |
152 |
$2K |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
8,903 |
8,255 |
$2K |
| 86920 |
|
127 |
92 |
$2K |
| 82652 |
|
49 |
48 |
$1K |
| 82677 |
|
80 |
80 |
$1K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
62 |
12 |
$1K |
| 83615 |
|
2,669 |
2,342 |
$1K |
| 86694 |
|
120 |
115 |
$1K |
| 73560 |
|
43 |
40 |
$1K |
| 86812 |
|
57 |
56 |
$1K |
| 82525 |
|
131 |
130 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
150 |
148 |
$1K |
| Q3014 |
Telehealth originating site facility fee |
976 |
935 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
25 |
25 |
$1K |
| 87107 |
|
195 |
178 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
84 |
76 |
$1K |
| 0001A |
|
51 |
48 |
$1K |
| 86146 |
|
71 |
68 |
$1K |
| 83835 |
|
103 |
92 |
$1K |
| 76937 |
|
64 |
62 |
$1K |
| 82239 |
|
77 |
64 |
$1K |
| 90677 |
|
14 |
14 |
$1K |
| 83921 |
|
89 |
89 |
$1K |
| 86703 |
|
158 |
150 |
$1K |
| 72040 |
|
25 |
24 |
$1K |
| ATP19 |
|
239 |
188 |
$1K |
| 90662 |
|
257 |
254 |
$1K |
| 91320 |
|
12 |
12 |
$1K |
| 83718 |
|
307 |
303 |
$1K |
| 82747 |
|
81 |
79 |
$1K |
| 82040 |
|
2,453 |
2,335 |
$1K |
| 70360 |
|
12 |
12 |
$1K |
| 84520 |
|
4,292 |
3,717 |
$994.47 |
| 97597 |
|
40 |
25 |
$964.42 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,921 |
1,640 |
$959.68 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
30,639 |
28,375 |
$952.53 |
| 80179 |
|
135 |
131 |
$884.96 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
765 |
699 |
$874.30 |
| J3411 |
Injection, thiamine hcl, 100 mg |
587 |
428 |
$858.41 |
| 82247 |
|
3,656 |
2,736 |
$854.04 |
| 83935 |
|
218 |
154 |
$790.54 |
| 82530 |
|
94 |
63 |
$788.48 |
| 86684 |
|
194 |
185 |
$758.67 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
750 |
683 |
$741.44 |
| 93290 |
|
70 |
66 |
$740.88 |
| 83090 |
|
138 |
137 |
$688.59 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
41 |
40 |
$683.84 |
| 73552 |
|
68 |
62 |
$683.77 |
| 76857 |
|
14 |
12 |
$671.72 |
| 80185 |
|
180 |
154 |
$653.71 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
4,301 |
3,807 |
$622.75 |
| 83021 |
|
55 |
55 |
$605.34 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
906 |
722 |
$599.22 |
| 90837 |
Psychotherapy, 53 minutes with patient |
208 |
114 |
$593.84 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
353 |
344 |
$564.28 |
| 93282 |
|
26 |
25 |
$558.98 |
| 70548 |
|
14 |
13 |
$552.56 |
| 84479 |
|
240 |
236 |
$552.05 |
| 85613 |
|
79 |
76 |
$547.43 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
1,348 |
1,271 |
$543.86 |
| 97162 |
|
14 |
14 |
$543.46 |
| 86880 |
|
142 |
122 |
$527.37 |
| 87807 |
|
54 |
54 |
$497.20 |
| 86021 |
|
57 |
55 |
$494.01 |
| 82340 |
|
179 |
172 |
$454.84 |
| 84155 |
|
629 |
614 |
$446.48 |
| 82378 |
|
52 |
51 |
$420.79 |
| 84134 |
|
83 |
67 |
$414.34 |
| 64494 |
|
252 |
207 |
$406.45 |
| 99307 |
|
112 |
102 |
$395.10 |
| J7510 |
Prednisolone oral, per 5 mg |
465 |
417 |
$377.93 |
| 86709 |
|
42 |
42 |
$369.96 |
| 73522 |
|
12 |
12 |
$367.75 |
| 73060 |
|
39 |
38 |
$367.06 |
| 90480 |
|
12 |
12 |
$366.96 |
| 80162 |
|
75 |
66 |
$356.99 |
| 85651 |
|
198 |
170 |
$354.01 |
| 88302 |
|
13 |
12 |
$352.70 |
| J1836 |
Injection, metronidazole, 10 mg |
90 |
62 |
$340.98 |
| 80143 |
|
154 |
148 |
$311.81 |
| 82172 |
|
24 |
24 |
$284.88 |
| 84295 |
|
416 |
379 |
$274.01 |
| 83930 |
|
81 |
75 |
$267.67 |
| 86430 |
|
115 |
109 |
$264.40 |
| 86381 |
|
258 |
255 |
$246.95 |
| 93923 |
|
18 |
18 |
$241.68 |
| G0008 |
Administration of influenza virus vaccine |
359 |
358 |
$237.25 |
| 86304 |
|
13 |
13 |
$227.88 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
62 |
40 |
$227.32 |
| 86870 |
|
13 |
12 |
$219.02 |
| 84080 |
|
32 |
31 |
$215.68 |
| 85390 |
|
27 |
26 |
$205.92 |
| 84466 |
|
25 |
25 |
$202.50 |
| 86300 |
|
54 |
41 |
$201.85 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
9,234 |
8,701 |
$192.18 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
241 |
166 |
$149.40 |
| 82164 |
|
12 |
12 |
$133.20 |
| 86645 |
|
12 |
12 |
$127.82 |
| 84075 |
|
415 |
394 |
$126.91 |
| J1790 |
Injection, droperidol, up to 5 mg |
361 |
306 |
$113.66 |
| 83695 |
|
13 |
13 |
$101.04 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
1,976 |
1,961 |
$95.84 |
| 87350 |
|
12 |
12 |
$94.59 |
| 36600 |
|
190 |
175 |
$93.21 |
| 82787 |
|
14 |
14 |
$87.72 |
| S0028 |
Injection, famotidine, 20 mg |
394 |
382 |
$86.43 |
| 86707 |
|
12 |
12 |
$83.51 |
| 82950 |
|
19 |
19 |
$79.61 |
| 88341 |
|
13 |
12 |
$70.94 |
| 87075 |
|
12 |
12 |
$69.12 |
| 87400 |
|
35 |
35 |
$65.64 |
| 85384 |
|
13 |
13 |
$62.00 |
| 80165 |
|
16 |
14 |
$55.08 |
| 82523 |
|
25 |
24 |
$32.96 |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
92 |
54 |
$28.23 |
| 84478 |
|
18 |
12 |
$25.30 |
| 87210 |
|
13 |
13 |
$22.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
103 |
73 |
$16.83 |
| 99441 |
|
14 |
12 |
$9.88 |
| 99152 |
|
3,458 |
3,346 |
$1.09 |
| 99153 |
Mod sedat endo service >5yrs |
3,213 |
3,112 |
$0.54 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
446 |
412 |
$0.20 |
| 84145 |
|
324 |
288 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
313 |
298 |
$0.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
1,658 |
1,311 |
$0.00 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
912 |
897 |
$0.00 |
| 51702 |
|
79 |
76 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
212 |
197 |
$0.00 |
| 80364 |
|
196 |
172 |
$0.00 |
| 86015 |
|
257 |
255 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
320 |
253 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
705 |
642 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
723 |
447 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
89 |
67 |
$0.00 |
| 77002 |
|
13 |
13 |
$0.00 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
22 |
14 |
$0.00 |
| 76376 |
|
27 |
25 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
208 |
196 |
$0.00 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
19 |
19 |
$0.00 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
36 |
35 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
24 |
24 |
$0.00 |
| 91300 |
|
55 |
52 |
$0.00 |
| 80348 |
|
51 |
40 |
$0.00 |
| 82653 |
|
55 |
53 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
14 |
13 |
$0.00 |
| 86036 |
|
13 |
13 |
$0.00 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
13 |
13 |
$0.00 |
| 98968 |
|
17 |
12 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,763 |
1,592 |
$0.00 |
| 80349 |
|
17 |
15 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,588 |
1,444 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
2,148 |
1,542 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
61 |
60 |
$0.00 |
| C1769 |
Guide wire |
1,147 |
1,052 |
$0.00 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
328 |
275 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
796 |
753 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
210 |
166 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
188 |
144 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
385 |
374 |
$0.00 |
| 99292 |
|
109 |
106 |
$0.00 |
| 80320 |
|
396 |
323 |
$0.00 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
396 |
382 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
13 |
13 |
$0.00 |
| 80329 |
|
61 |
58 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
60 |
55 |
$0.00 |
| 74175 |
|
73 |
72 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
47 |
41 |
$0.00 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
26 |
25 |
$0.00 |
| 76377 |
|
19 |
18 |
$0.00 |
| 80359 |
|
13 |
12 |
$0.00 |
| 80324 |
|
20 |
16 |
$0.00 |